Cardiovascular (CV) disease remains an important cause of morbidity and mortality for
patients with chronic kidney disease (CKD). Although clustering of traditional risk factors with …

Despite marked improvements in renal replacement therapy during the last 30 years, the
age-adjusted mortality rate in end-stage renal disease (ESRD) patients is still unacceptably …

Results Circulating endotoxemia was most notable in those with the highest CV disease
burden (increasing with CKD stage), and a sharp increase was observed after initiation of …

Elevated fibroblast growth factor 23 (FGF23) is associated with cardiovascular disease in
patients with chronic kidney disease. As a potential mediating mechanism, FGF23 induces …

Premature cardiovascular disease (CVD), including stroke, peripheral vascular disease,
sudden death, coronary artery disease, and congestive heart failure, is a notorious problem …

Background and objectives: Hemodialysis (HD)-induced regional wall motion abnormalities
(RWMAs) are common in HD patients and driven by ischemia. In nondialysis patients …

Background and objectives: Vascular calcification is increasingly recognized as an
important component of cardiovascular disease in chronic kidney disease. The objective of …

Background. Vascular calcification has detrimental consequences on chronic kidney
disease (CKD) patients, yet its pathogenesis is not fully understood. Fibroblast growth factor …

Coronary calcification has long been known to occur as a part of the atherosclerotic process,
although whether it is a marker of plaque stability or instability is still a topic of considerable …

Background. Vascular calcification (VC) and arterial stiffness are major contributors to
cardiovascular (CV) disease in chronic kidney disease (CKD). Both are independent …